Literature DB >> 3955528

Translocation (13;22) in a hemangiopericytoma.

J Limon, U Rao, P Dal Cin, Z Gibas, A A Sandberg.   

Abstract

Cytogenetic studies on primary hemangiopericytoma tumor cells from a 28 year old woman showed a single karyotypic change: t(13;22)(q22;q11). The relationship of this aberration to previously described abnormalities of chromosome #22 in other solid tumors is discussed.

Entities:  

Mesh：

Year:  1986        PMID： 3955528     DOI： 10.1016/0165-4608(86)90211-6

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN： 0165-4608


  6 in total

1.  Morphological and cytogenetic studies of angiosarcoma in Stewart-Treves syndrome.

Authors:  L G Kindblom; G Stenman; L Angervall
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Regional localization and molecular characterization of a DNA sequence on the long arm of chromosome 22.

Authors:  E Göttert; R Metzdorf; U Färber; N Blin
Journal:  Hum Genet       Date:  1989-03       Impact factor: 4.132

3.  Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene.

Authors:  K Hagiwara; G Stenman; H Honda; P Sahlin; A Andersson; K Miyazono; C H Heldin; F Ishikawa; F Takaku
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

4.  The contribution of cytogenetics to the histogenesis of meningeal hemangiopericytoma.

Authors:  H Zattara-Cannoni; M O North; D Gambarelli; D Figarella-Branger; N Graziani; F Grisoli; A M Vagner-Capodano
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

Review 5.  Cytogenetics of cranial base tumors.

Authors:  S M Gollin; I P Janecka
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  NF2 gene analysis distinguishes hemangiopericytoma from meningioma.

Authors:  J T Joseph; D K Lisle; L B Jacoby; W Paulus; R Barone; M L Cohen; W H Roggendorf; J M Bruner; J F Gusella; D N Louis
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.